Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04720300 · ClinicalTrials.gov registry record · NA
Evaluating a Travel App's Influence on College Student Commuting to Campus
A NA study, sponsored by Florida Atlantic University.
- Completed
- Registry status
- NA
- Development phase
- 450
- Enrollment target
NCT04720300: Completed NA study, sponsored by Florida Atlantic University.
NCT04720300 is a NA study that has completed, run by Florida Atlantic University. The registered enrollment target is 450 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04720300, a NA study, has completed, sponsored by Florida Atlantic University.
- COMPLETED
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
Study Summary
The Cluster Randomized Controlled Trial (cRCT) portion of the study will focus on evaluating the use of information, marketing, and incentives to shape student travel behavior to campus through the three channels identified in Ajzen's (1991) framework.
Primary Outcome
Percentage of trips taken to campus by alternative modes. Will students in the intervention group, subject to information and marketing incentives as delivered through a MaaS app, be more likely to use alternative modes to reach campus?
Interventions
- OTHER MaaS app
- OTHER No app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT04720300 record still lists
NCT04720300 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which MaaS app is the first listed.
NCT04720300 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04720300 about?
NCT04720300 is a clinical study titled "Evaluating a Travel App's Influence on College Student Commuting to Campus". The Cluster Randomized Controlled Trial (cRCT) portion of the study will focus on evaluating the use of information, marketing, and incentives to shape student travel behavior to campus through the three channels identified in Ajzen's (1991) framework.
What is the current status of trial NCT04720300?
This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2022-02-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04720300?
The interventions under investigation include: MaaS app (OTHER), No app (OTHER).
Who is sponsoring clinical trial NCT04720300?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04720300's enrollment target sits among peer trials
450 225th of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI